Comparison of the effect of botulinum toxin a in patients with migraine headaches and treatment-resistant tension in people aged 20 to 70 in patients

Comparison of the effect of botulinum toxin a in patients with migraine headaches and treatment-resistant tension in people aged 20 to 70 years

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250308064974N1

Enrollment

Registered

2025-09-29

Start date

2025-10-23

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migrain and tension headache. Migraine

Interventions

Intervention 1: First Intervention groupPatients with treatment-resistant chronic migraine headaches are in the first intervention group, receiving botulinum toxin type A subcutaneously with a fine in

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: All patients aged 20 to 70 years Patients with treatment-resistant migraine headache Patients with treatment-resistant tesion headache

Exclusion criteria

Exclusion criteria: Age less than 20 and more than 70 years

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 4 ,8 ,12 weaks after injection. Method of measurement: The Visual Analogue Scale.	—

Secondary

Measure	Time frame
Time of pain. Timepoint: 4 ,8 ,12 week after injection. Method of measurement: Time if headache (hours).;Number of headache attacks per week. Timepoint: 4, 8 ,12 weeks after injection. Method of measurement: Number of headache attacks per week.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFateme Tabrizi

Ghoum University of Medical Sciences

tabeizi223@gmail.com+98 25 3612 2526

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026